Polarized Reflectance Spectroscopy for Oral Lesions (PolProbe)
Evaluation of Polarized Reflectance Spectroscopy for Detection of High-risk Oral Lesions
In this study the investigators are conducting research to determine whether a new optical device using polarization reflectance spectroscopy can help doctors or dentists identify abnormalities in the mouth that require follow-up. To establish this, measurements are needed from a large number of individuals with different abnormalities in their mouth.
The investigators believe the proposed approach has potential to improve and enable mass screening for precancerous and early cancers of the oral cavity by improving the predictive value of oral cavity exams, particularly for less experienced practitioners.
The information from this study will be compared to results from the pathology report of the tissue taken from your mouth.
Hypothesis:
- Polarized reflectance spectroscopy can distinguish high-risk oral lesion from normal and reactive oral lesions.
- Polarized reflectance spectroscopy can capture low-grade oral lesions that have characteristics associated with a high risk of progression to cancer.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The clinician will place a fiber-optic probe designed to measure the polarized reflectance spectra over the visible optical region on a site of interest in the subject's mouth, including lesional mucosa, normal adjacent and contralateral mucosa. The site for placement of the probe will be determined by the examiner, an experienced Oral Pathologist. The probe examination will take no more than 15 minutes in addition to the subject's appointment time for their routine visits.
A 4um unstained tissue section from surgery or biopsy, part of their scheduled care, will be requested for quantitative histological analysis. The morphometric parameters obtained from polarized reflectance measurements will be compared with the histology and quantitative pathology (nuclear phenotype score) from the tissue sections from the lesion. The collected spectra data from normal looking areas from adjacent normal looking mucosa and contralateral mucosa will be used to determine patient to patient variation in the polarized reflectance of oral mucosa.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 1
Kontakter och platser
Studieorter
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 1L3
- British Columbia Cancer Agency - Vancouver Centre
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- You attend the Dental Department at the British Columbia Cancer Agency
- You have an abnormal lesion in the mouth
- You fully understand the study and give your informed consent to participate as demonstrated by signing this consent form
Exclusion Criteria:
- You are under the age of 18 years.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Övrig: Polarized probe measurement.
All patients belong under this arm as all will be measured by the polarized probe and the data will be compared to the biopsy site's pathology results.
|
Fiber optic probe designed to measure polarized reflectance spectroscopy will be used to gather data from all study participants.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
To use the spectroscopic data collected to create a model for normal, dysplastic and cancerous tissue.
Tidsram: 2 years
|
The goals of the statistical analysis will be to determine an appropriate model for predicting whether the lesion is normal or abnormal (dysplasia or carcinoma) based on spectroscopic characteristics.
The investigators will estimate sensitivity and specificity of the predictions made by the model and compare this to sensitivity and specificity of standard white light clinical examination currently used in clinical practice.
|
2 years
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Catherine Poh, M.D. Ph.D, British Columbia Cancer Agency
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- H10-01313
- 5RO1EB00354004 (PC-1) (Annat bidrag/finansieringsnummer: NIH)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Oral cancer
-
University of PalermoRekryteringOral Lichen Planus | Oral mukosal sjukdom | Oral Lichen Planus-relaterad stress | Oral smärtaItalien
-
Masaryk UniversityAvslutadKlorhexidin | Oral mikrobiota | Salivmikrobiom | Antimikrobiell resistens (AMR) | Oral mikrobiom hälsaTjeckien
-
Anil ChaturvediNational Taiwan University HospitalRekryteringOral cancer | Oral Cancertestning | Oral PrekancerTaiwan
-
SÜMEYYE BİLGİLİ TEKİNAtaturk UniversityRekryteringOral komplikationTurkiet (Türkiye)
-
Universiti Putra MalaysiaHar inte rekryterat ännu
-
M3 HealthSão Paulo State UniversityHar inte rekryterat ännu
-
Samara State Medical UniversityRekryteringOral mikrobiotaRyska Federationen
-
Colgate PalmoliveAvslutad
-
Novozymes A/SAvslutadOral MalodorFörenta staterna
Kliniska prövningar på Polarized Reflectance Spectroscopy System
-
Inonu UniversityAvslutadDödlig fetma | Anestesimedvetenhet | AnestesikomplikationKalkon